FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

392911000001101: Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1857581000001110 Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1857591000001112 Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Is a Product containing precisely rifampicin 150 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has active ingredient Rifampicin false Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has specific active ingredient Rifampicin true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) 100 capsule Is pack of False Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) 100 capsule Has AMP True Rifampicin 150mg capsules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start